JPS58225059A - Pantethine tetraoctanoyl ester compound and skin quality improving agent containing said pantethine tetraoctanoyl ester compound - Google Patents

Pantethine tetraoctanoyl ester compound and skin quality improving agent containing said pantethine tetraoctanoyl ester compound

Info

Publication number
JPS58225059A
JPS58225059A JP10904582A JP10904582A JPS58225059A JP S58225059 A JPS58225059 A JP S58225059A JP 10904582 A JP10904582 A JP 10904582A JP 10904582 A JP10904582 A JP 10904582A JP S58225059 A JPS58225059 A JP S58225059A
Authority
JP
Japan
Prior art keywords
pantethine
skin
tetraoctanoyl
ester compound
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10904582A
Other languages
Japanese (ja)
Inventor
Toshimitsu Suzuki
利光 鈴木
Hiroyuki Nakano
中野 博行
Koji Utsugi
宇都木 康二
Goro Takahashi
五郎 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Orbis Holdings Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Priority to JP10904582A priority Critical patent/JPS58225059A/en
Publication of JPS58225059A publication Critical patent/JPS58225059A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

NEW MATERIAL:A pantethine tetraoctanoyl ester compound of the formula (R is 8C straight chain acyl). USE:A skin quality improving agent, capable of improving the abnormality in lipid metabolism, e.g. the skin roughness or chapped skin, etc. and effective for improving fine wrinkles, texture of the skin, tensity and chromatosis, etc., and stable to heat and light without causing changes with time, e.g. discoloration, change in smell, decomposition, inactivation, etc. even in formulating as a pharmaceutical, nor toxicity or skin disorder. PROCESS:Pantethine is reacted with octylic acid chloride in a solvent, e.g. quinoline, pyridine or dimethylformamide, in the presence of a base, e.g. triethylamine, to give the compound of the formula. In case a basic solvent, e.g. the pyridine or quinoline, is used, the reaction is carried out in the absence of the base. The amount of the octylic acid chloride to be used is 4.4-6.9 equivalents based on one equivalent pantethine.

Description

【発明の詳細な説明】 本発明は新規パンテチンテトラオクタノイルエステル化
合物及びこれを配合してなる肌質改善剤に関するもので
ある。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel pantethine tetraoctanoyl ester compound and a skin quality improving agent containing the same.

一般K、皮膚での異常特に脂質代部の異常は、皮脂腺に
おける機能の障害により生ずるものと考えられ、外観的
には肌荒れ、荒れ症などのような11フ燥性の症状とし
て現われたり、逆に皮脂分泌過多に伴うにぎびの生成な
どの症状がみられる。そのほか肌質の異常としては色素
沈着症例えばしみ、そばかす、色黒などの症状もみられ
る。
General K. Abnormalities in the skin, especially abnormalities in the lipid glands, are thought to be caused by dysfunction in the sebaceous glands, and may appear as dry skin symptoms such as rough skin or chapped skin, or vice versa. Symptoms such as acne formation due to excessive sebum secretion are observed. Other skin abnormalities include hyperpigmentation, such as age spots, freckles, and dark skin.

従来これら肌荒れや荒れ症に対処して肌を正常化する為
の物質としては胎盤製剤やビタミン類が主に用いられて
いたが、本質的な意味での充分な効果は得られていない
。そのほか男性ホルモンを用いる方法もあるが、これを
過剰に使用すると皮脂分泌の均衡を変化させ、かえって
正常な代謝を妨げるおそれがある。また皮脂分路の過多
に対しては女性ホルモンの使用が考えられるが、男性ホ
ルモンとは反対に乾燥性の症状が過度に顕在化する傾向
があり、いずれも満足できるものではない。
Conventionally, placenta preparations and vitamins have been mainly used as substances to normalize the skin by dealing with rough skin and rough skin, but they have not been sufficiently effective in an essential sense. Other methods include the use of male hormones, but excessive use of these can alter the balance of sebum secretion and may even interfere with normal metabolism. Furthermore, the use of female hormones can be considered to treat excessive sebum shunts, but in contrast to male hormones, dryness symptoms tend to become excessively evident, so neither method is satisfactory.

そこで本発明者らは皮膚内における脂質代謝を症状の態
様に応じて調節することかでき、肌荒れ、荒れ症、皮脂
分泌の過多などの脂質代謝の異常に基づく変化の改善な
らびに色素沈着症などの肌質異常に効果のある新規な物
質を開発する為、鋭意研究し之結果、新規ノξンテチン
テトラオクタノイ七エステル化合物を合成し、さらにこ
れを必須成体として肌質改善剤に配合することにより本
発明を完成させた。
Therefore, the present inventors have found that it is possible to adjust lipid metabolism in the skin according to the aspect of symptoms, and to improve changes caused by abnormalities in lipid metabolism such as rough skin, chapped skin, and excessive sebum secretion, as well as to improve pigmentation and other disorders. In order to develop a new substance that is effective for skin abnormalities, as a result of intensive research, we synthesized a new ξ-ntetine tetraoctanoyl heptester compound, and further added this as an essential compound to a skin quality improving agent. As a result, the present invention was completed.

本発明は一般式(1) (式中Rは炭素数8の直鎖アシル基を表わす。)で示さ
れる新規なパンテチンテトラオクタノイルエステル化合
物及びパンテチンテトラオクタノイルエステル化合物を
必須成分として配合することを特徴とする肌質改善剤に
関するものである。
The present invention includes a novel pantethine tetraoctanoyl ester compound and a pantethine tetraoctanoyl ester compound represented by the general formula (1) (in which R represents a straight chain acyl group having 8 carbon atoms) as essential components. The present invention relates to a skin quality improving agent characterized by the following.

本発明の新規な、tlンテチンテトラオクタノイルエス
テル化合物は熱及び光に対して極めて安定であり、製剤
とした場合も変色、変臭、分解失活などの経時変化を起
こさず、また各種外用基剤に対して容易に配合すること
ができる点で極めて有利である。さらに毒性や皮膚障害
の心配は全くなく、安全に用いることができるものであ
る。
The novel tl-ntetine tetraoctanoyl ester compound of the present invention is extremely stable against heat and light, and does not undergo changes over time such as discoloration, odor, or decomposition and inactivation even when made into a preparation, and can be used for various external purposes. It is extremely advantageous in that it can be easily blended into the base. Furthermore, there is no concern about toxicity or skin damage, and it can be used safely.

本発明のパンテチンテトラオクタノイルエステル化合物
の製法としては、パンテチンをキノリン、ピリジン、ジ
メチルホルムアミド(DMF )、ジメチルスルホキサ
イド(DM80 ) 、ヘキサメチルホスホトリアミド
(HM9Tt、 )等の極性溶媒に溶解し、トリエチル
アミン等の塩基存在下(但し、ピリジン、キノリン等塩
基性溶媒使用時は除く)、オクチル酸クロライドを作用
させエステル化反応を行なう(酸塩化物法)のが最も一
般的であるが、その他にもジシクロへキシルカルボジイ
ミド法(DCC法)等によっても合成可能である。酸塩
化物法を用いた時の方法としては、ノ々ンテチンを脱酸
効果を有する溶媒(例えばピリジン、キノリン等)に溶
解、またはトリエチルアミン等の塩基を含む極性溶媒(
例えばDMF%DMSO,HMPT等)に溶解し、これ
にオクチル酸クロライドを反応させ目的のエステル化物
を得る。オクチル酸クロライドの蓋としては、・ζンテ
チン1当址に苅し4.4〜6.0当量使用することが好
ましい。反応は副反応を押える為当初冷却下で行なわれ
、次いで室温まで温度を上げて反応を完結する。精製は
通常の方法、例えばカラムクロマトグラフィー等により
行なわれる。以下に本発明化合物の合成例を示す。
The method for producing the pantethine tetraoctanoyl ester compound of the present invention involves dissolving pantethine in a polar solvent such as quinoline, pyridine, dimethylformamide (DMF), dimethyl sulfoxide (DM80), or hexamethylphosphotriamide (HM9Tt). The most common method is to carry out an esterification reaction with octylic acid chloride in the presence of a base such as triethylamine (however, when using a basic solvent such as pyridine or quinoline) (acid chloride method), but other It can also be synthesized by the dicyclohexylcarbodiimide method (DCC method). When using the acid chloride method, nonantechin can be dissolved in a solvent that has a deoxidizing effect (e.g. pyridine, quinoline, etc.), or in a polar solvent containing a base such as triethylamine (
(For example, DMF% DMSO, HMPT, etc.) and reacted with octylic acid chloride to obtain the desired esterified product. As a cover for octylic acid chloride, it is preferable to use 4.4 to 6.0 equivalents per 1 equivalent of ζntetine. The reaction is initially carried out under cooling to suppress side reactions, and then the temperature is raised to room temperature to complete the reaction. Purification is carried out by conventional methods such as column chromatography. Examples of synthesis of the compounds of the present invention are shown below.

合成例1 パンテチンテトラオクタノイルエステル/ζ
ンテテ755.5F(0,1mol )をピリジン50
011Itに溶解し、水冷下オクチル酸クロライド81
.3 t(0,5mol)を徐々に滴下した。滴下終了
後、室温でさらに3時間攪拌し、反応を完結させた。反
応終了後、ピリジンを減圧下笛去し、次いで残渣に酢酸
エチル1tと水1・tを加え抽出した。酢酸エチル層を
取り出し、減圧上酢酸エチルを留去し粗生成物を得た。
Synthesis Example 1 Pantethine tetraoctanoyl ester/ζ
Ntete 755.5F (0.1 mol) in pyridine 50
Octylic acid chloride 81 was dissolved in 011It and cooled with water.
.. 3 t (0.5 mol) was gradually added dropwise. After the dropwise addition was completed, the mixture was further stirred at room temperature for 3 hours to complete the reaction. After the reaction was completed, pyridine was removed under reduced pressure, and then 1 t of ethyl acetate and 1 t of water were added to the residue for extraction. The ethyl acetate layer was taken out, and ethyl acetate was distilled off under reduced pressure to obtain a crude product.

さらに得られた粗生成物は、シリカゲルカラムを用い、
n−へキサン:エタノール=9=1の混合溶媒を用いて
展開し、目的のテトラオクタノイルパンテチンを得た。
Furthermore, the obtained crude product was purified using a silica gel column.
The reaction mixture was developed using a mixed solvent of n-hexane:ethanol=9=1 to obtain the desired tetraoctanoylpantethine.

性状は粘稠液体であった。The substance was a viscous liquid.

収jjk74.2t(収率70%) 元素分析値 CHN    S 実験値 61.16 9.41 5,16 5.99理
論値 61.20 9.26 5.28 6.04赤外
部吸収      (第1図参照)3600副−I  
      CO−悲伸縮振動2950〜2850 c
m−10−H伸縮振動1740 cm−’      
  −C−0−伸縮振動1660画一1      −
C−NH−伸縮振動1240〜1160cm ’   
 −C−0−(ニー伸縮振動NMRδ値(CDCl3 
、 TMS基準)3.6 (C0NHC抛−)、2.9
(−〇±−5−s−c血−)。
Yield jjk74.2t (yield 70%) Elemental analysis value CHN S Experimental value 61.16 9.41 5,16 5.99 Theoretical value 61.20 9.26 5.28 6.04 Infrared absorption (Fig. 1 Reference) 3600 sub-I
CO-Sad stretching vibration 2950~2850c
m-10-H stretching vibration 1740 cm-'
-C-0-Stretching vibration 1660 strokes 1-
C-NH-Stretching vibration 1240-1160cm'
-C-0- (knee stretching vibration NMRδ value (CDCl3
, TMS standard) 3.6 (C0NHC), 2.9
(-〇±-5-s-c blood-).

2.4 (−CH2CO−)、1.3〜0.9 (−C
H2−(!H5)次に本発明によって得られたノξンテ
チンテトラオクタノイルエステルの安定性に関する評価
をビタミンCとの比較において示す。
2.4 (-CH2CO-), 1.3-0.9 (-C
H2-(!H5) Next, an evaluation regarding the stability of nonξntetine tetraoctanoyl ester obtained by the present invention will be shown in comparison with vitamin C.

試験例 ノζンテチンテトラオクタノイルエステル95チェタノ
ール溶液及びビタミンC95%エタノール1容液の熱、
光及び経時変化に対する安定性試験を行なった。
Test Example: Heat of ζntetine tetraoctanoyl ester 95 cetanol solution and 1 volume of vitamin C 95% ethanol,
Stability tests against light and changes over time were conducted.

試験方法は下記(a)〜(C)のとおりで、試料はパン
テチンテトラオクタノイルエステル及びビタミンC各々
1チを含有した95%エタノール溶液を用いた。
The test methods were as shown in (a) to (C) below, and the sample used was a 95% ethanol solution containing 1 part each of pantethine tetraoctanoyl ester and vitamin C.

(a)  熱安定性=80℃で3時間放置(b)  光
安定性:太陽光を3日間照射(C)  経時安定性:4
0℃で6チ月放置クタノイルエステルはすべての点でビ
タミンCよりも安定性に優れ、製剤としてもその効果が
期待される。
(a) Thermal stability = left at 80°C for 3 hours (b) Photostability: irradiated with sunlight for 3 days (C) Stability over time: 4
Cutanoyl ester left at 0°C for 6 months has better stability than vitamin C in all respects, and is expected to be effective as a preparation.

第1表 養1TOP:zeンテチンテトラオクタノイルエステル
餐2  Vc  :ビタミンC 残存率:◎:90チ以上 ○:80〜90チΔ:60〜
80チ ×:60チ未満 変 臭ニー:なし  士:ややあり  +:あり次に本
発明新規パンテチンテトラオクタノイルエステル化合物
を必須成分として配合した肌質改善剤について説明する
1st Tablet 1 TOP: Zentetin Tetraoctanoyl Ester Meal 2 Vc: Vitamin C Residual Rate: ◎: 90+ ○: 80-90+ Δ: 60-
80 x: Less than 60 x Odor: None Odor: Slightly +: Yes Next, a skin quality improving agent containing the novel pantethine tetraoctanoyl ester compound of the present invention as an essential ingredient will be described.

本発明によれば新規パンテチンテトラオクタノイルエス
テルは賦形剤、希釈剤、補助剤等と共K、クリーム、ロ
ーション、粉末剤、軟膏などの形で用いられる。これら
の化粧料及び医薬用製剤は常法により製造できる。
According to the present invention, the novel pantethine tetraoctanoyl ester is used in the form of creams, lotions, powders, ointments, etc. together with excipients, diluents, adjuvants, etc. These cosmetics and pharmaceutical preparations can be manufactured by conventional methods.

本発明の肌質改善剤に含有されるパンテチンテトラオク
タノイルエステルの含有量は通常0.01〜511L!
%、好ましくは01〜1重量%である。0.01重量%
より少ない量では充分な効果が得られない。
The content of pantethine tetraoctanoyl ester contained in the skin quality improving agent of the present invention is usually 0.01 to 511 L!
%, preferably 01-1% by weight. 0.01% by weight
A sufficient effect cannot be obtained with a smaller amount.

また5重址チを超える量では効果の増強がなく不経済で
ある。
Moreover, if the amount exceeds 5 times, the effect will not be enhanced and it will be uneconomical.

次に本発明に係る新規ノ々ンテチンテトラオクタメイル
エステル配合の肌質改善剤の実施例を示す。
Next, examples of the novel skin quality improving agent containing nonantechin tetraoctamail ester according to the present invention will be shown.

下記実施例中の部は重量を意味する。Parts in the examples below refer to weight.

実施例1 (皮膚用クリーム) に) スクアラン       10.0部ワセリン 
       10.0部 蜜ろ う         50部 マイクロワックス     90部 鯨ろ う          3.0部イソプロピルミ
リステート    12.0部ソルビタンモノステアレ
ート5.0部 パラオキシ安息香酸メチル     0.1部@1,3
−ブタンジオール  io、o部蒸  留  水   
        32.8部(C)香料     0.
5部 油性成分囚及び水性成分(B)を別個に80℃に加熱し
て溶解し、両者を混合して乳化する。次いで冷却しなが
ら香料C)を加え、30℃まで冷却して本島とする。
Example 1 (Skin cream) Squalane 10.0 parts Vaseline
10.0 parts Beeswax 50 parts Micro wax 90 parts spermaceti 3.0 parts Isopropyl myristate 12.0 parts Sorbitan monostearate 5.0 parts Methyl paraoxybenzoate 0.1 part @1,3
-Butanediol io, o part distilled water
32.8 parts (C) Fragrance 0.
5 parts The oily component and the aqueous component (B) are separately heated to 80° C. to dissolve them, and the two are mixed and emulsified. Next, fragrance C) is added while cooling, and the mixture is cooled to 30° C. to form the main island.

実施例2 (皮膚用クリーム) (4) セタノール        6.5部鯨ろ う
         3.0部 ラノリン         2.0部 流動パラフィン     20.0部 抗酸化剤        o、i部 ンルビタンモノオレート      2.0 部ポリオ
キシエチレンモノオレート  6,5部0) グリセリ
ン        10.0部蒸  留  水    
      52.0部(C)   香    料  
         0.4部(ト)及び(B)を別個に
80℃に加熱して溶解し、両者を混合乳化し、冷却して
香料を加え、均一に分散して製品とする。
Example 2 (skin cream) (4) Setanol 6.5 parts spermaceti 3.0 parts Lanolin 2.0 parts Liquid paraffin 20.0 parts Antioxidant o, i parts Rubitan monooleate 2.0 parts Polyester Oxyethylene monooleate 6.5 parts 0) Glycerin 10.0 parts Distilled water
52.0 parts (C) Fragrance
0.4 parts (g) and (B) are separately heated to 80° C. and dissolved, both are mixed and emulsified, cooled, fragrance is added, and the product is uniformly dispersed.

実施例3 (皮膚用軟膏) イソプロピルミリステート    10.0部セタノー
ル       10.0部 カーボワックス      5.0部 (J3)  流動ノζラフイン     590部パラ
フインワンクス    5.0部 (ロ)成分を加温俗解して均一となし、これに(ト)成
分の混合物を加え、冷却したのち混合して製品とする。
Example 3 (Skin ointment) Isopropyl myristate 10.0 parts Setanol 10.0 parts Carbowax 5.0 parts (J3) Fluid Zeta Rough-in 590 parts Paraffin Wanx 5.0 parts (B) Ingredients heated and dissolved Add the mixture of component (g) to this, cool and mix to obtain a product.

実施例4 (皮膚用パウダー) (ロ)  タ   ル  り            
    95部亜鉛華    2部 ステアリン酸亜鉛     2部− (B)  ハンチチンテトラオクタノイルエステル  
          1部(0香   料      
 適量 パンテチンテトラオクタノイルエステル(靭を溶媒に溶
解し、これを(ロ)の粉体成分によく混合分散したのち
、溶媒を留去し、香料(0を加え、次いで乾燥して製品
とする。
Example 4 (Skin powder) (b) Tarri
95 parts zinc white 2 parts zinc stearate 2 parts - (B) Hanchitin tetraoctanoyl ester
1 part (0 fragrance
After dissolving an appropriate amount of pantethine tetraoctanoyl ester (tough) in a solvent and thoroughly mixing and dispersing it in the powder component (b), the solvent is distilled off, perfume (0) is added, and the product is obtained by drying.

実施例5 (アクネ用ローション) ポリオキシエチレンラウリル エーテル              1.0部t−メ
ントール       0.05部プロピレングリコー
ル     5.0部パンテチンテトラオクタノイ ルエステル            0.5部    
    、1アルコール        15.0部香
    料            0.5部前記の成
分に蒸留水を加えて全zioo部とする。
Example 5 (Acne lotion) Polyoxyethylene lauryl ether 1.0 parts t-menthol 0.05 parts Propylene glycol 5.0 parts Pantethine tetraoctanoyl ester 0.5 parts
, 1 alcohol 15.0 parts Fragrance 0.5 parts Distilled water is added to the above ingredients to make a total of 1.5 parts.

本発明に係るパンテチンテトラオクタノイルエステルを
有効成分として配合した肌質改善剤は脂質代謝の改善に
効果のあるといわれているビタミン類やホルモン類を用
いたものよりはるかに著効を有する。本則は外用剤とし
て皮膚に直接塗布することにより、肌荒れ、荒れ症など
の脂質代謝の異常を改善するだけでな(、小じわ、肌の
きめ、はり等の改善にも効果がみられる。
The skin quality improving agent containing pantethine tetraoctanoyl ester as an active ingredient according to the present invention is far more effective than those using vitamins and hormones, which are said to be effective in improving lipid metabolism. The basic rule is that by applying it directly to the skin as an external preparation, it not only improves abnormalities in lipid metabolism such as rough skin and chapped skin (it is also effective in improving fine wrinkles, skin texture, firmness, etc.).

本発明の肌質改善剤を用い脂質代謝の改善及び色素沈着
症の治療効果を検討し、あわせて市販のビタミンE含有
クリームと比較した。適用方法としては、実施例1〜6
の製品を、肌荒れ、荒れ症、にきび、しみなどの肌質異
常を呈する28〜45才の女性60名の顔面患部に1日
朝及び就寝前の2回ずつ3力月間継続し7て塗布し、適
用患部の治療状態を観察して報告させた。その結果を第
2表に示す。本発明の肌質改善剤は市販品より著しく優
れていることが知られる。特Kかなシ悪化した症状を呈
する6名の女性に対し、本発明の肌質改善剤は優れた効
果を示した。
The effects of improving lipid metabolism and treating hyperpigmentation using the skin quality improving agent of the present invention were investigated, and compared with a commercially available vitamin E-containing cream. Examples 1 to 6 are applicable methods.
The product was applied to the affected areas of the faces of 60 women aged 28 to 45 with skin abnormalities such as rough skin, rough skin, acne, and age spots, twice a day in the morning and before going to bed for three months, and The treatment status of the affected area was observed and reported. The results are shown in Table 2. It is known that the skin quality improving agent of the present invention is significantly superior to commercially available products. The skin quality improving agent of the present invention showed excellent effects on 6 women with particularly worsening symptoms.

に)改善程度は、自己判定して 1:変化なし 2:やや改善されたような気がする 3:やや改善された 4:明らかに改善された の各段階に区別し、その平均値を表中に示した。) The degree of improvement is self-assessed. 1: No change 2: I feel like it has improved somewhat. 3: Slightly improved 4: Clearly improved The average value is shown in the table.

Q3)市販品との比較は、半顔比較法を用い、3:本則
が極めて優れている 2:本則がやや優れている 1:本則と同等 の各段階に区別し7、その平均値を表中に示した。
Q3) Comparisons with commercially available products are made using the half-face comparison method. 3: The main rule is extremely good. 2: The main rule is slightly better. 1: Equivalent to the main rule. 7. The average value is shown. Shown inside.

第2表Table 2

【図面の簡単な説明】[Brief explanation of drawings]

第1図は合成例1の方法で作られたバンテテンテトラオ
クタノイルエステルの赤外部吸収スRクト ル。 特許出願人 ポーラ化成工業株式会社
Figure 1 shows the infrared absorption spectrum of bantetentetraoctanoyl ester prepared by the method of Synthesis Example 1. Patent applicant: POLA CHEMICAL INDUSTRIES, INC.

Claims (2)

【特許請求の範囲】[Claims] (1)一般式(1) (式中Rは炭素88の直鎖アシル基を表わf。)で示さ
れるパンテチンテトラオクタノイルエステル化合物
(1) Pantethine tetraoctanoyl ester compound represented by the general formula (1) (wherein R represents a carbon 88 linear acyl group, f.)
(2)一般式(1) (式中Rは炭素数8の直鎖アシル基を表わす。)で示さ
れるノぐンテチンテトラオクタノイルエステル化合物を
必須成分として配合することを特徴とする肌質改善剤
(2) Skin quality characterized by containing a noguntechine tetraoctanoyl ester compound represented by the general formula (1) (in which R represents a straight-chain acyl group having 8 carbon atoms) as an essential component. improving agent
JP10904582A 1982-06-24 1982-06-24 Pantethine tetraoctanoyl ester compound and skin quality improving agent containing said pantethine tetraoctanoyl ester compound Pending JPS58225059A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10904582A JPS58225059A (en) 1982-06-24 1982-06-24 Pantethine tetraoctanoyl ester compound and skin quality improving agent containing said pantethine tetraoctanoyl ester compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10904582A JPS58225059A (en) 1982-06-24 1982-06-24 Pantethine tetraoctanoyl ester compound and skin quality improving agent containing said pantethine tetraoctanoyl ester compound

Publications (1)

Publication Number Publication Date
JPS58225059A true JPS58225059A (en) 1983-12-27

Family

ID=14500204

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10904582A Pending JPS58225059A (en) 1982-06-24 1982-06-24 Pantethine tetraoctanoyl ester compound and skin quality improving agent containing said pantethine tetraoctanoyl ester compound

Country Status (1)

Country Link
JP (1) JPS58225059A (en)

Similar Documents

Publication Publication Date Title
US4145413A (en) Artificial skin darkening composition and method of using the same
JPH10183001A (en) Production of composite melanin pigment particle containing spherical core of wax and its use for cosmetic
EP0655453A1 (en) A benzophenone derivative, and ultraviolet light absorbent and an endermic liniment
JPS6391362A (en) Unsaturated aromatic peroxides and use for remedy and cosmetic
JP2003527411A (en) Method for preparing a high pressure / high shear dispersion containing a physiologically active ingredient
JP3424930B2 (en) N-acylglutamine derivatives
DE3833706C2 (en) New t-butyl derivatives of benzylidene camphor, process for their preparation and pharmaceutical and cosmetic compositions containing them
JPH09176138A (en) New l-oxothiazolidine-4-carboxylic acid derivative and its use for skin care
CA1142854A (en) Method and compositions for the treatment of seborrhea
IE54244B1 (en) Cosmetic hair-care and skin-care compositions
JPH108049A (en) Antioxidant composition
JP2742982B2 (en) Active oxygen scavenger
JPH1017436A (en) Skin preparation for external use
JPS6256411A (en) Beautifying agent
JPH08208710A (en) Cyclic inulooligosaccharide derivative and cosmetic containing the same
JP2931763B2 (en) Novel lysine derivative, method for producing the same and cosmetic composition containing the same
JPS6127367B2 (en)
JPS58225059A (en) Pantethine tetraoctanoyl ester compound and skin quality improving agent containing said pantethine tetraoctanoyl ester compound
JPS58128310A (en) Skin conditioner
JPH07149622A (en) Beautifying and whitening preparation
JPS6328070B2 (en)
JPS62215512A (en) Cosmetic
JPS60116616A (en) Cosmetic
JPH0632710A (en) Skin external preparation
JPH01249885A (en) Antioxidant for lipid